Skip to content
20-F

Annual Report (Foreign)

Akso Health Group AHG

0001213900-23-057106

← back to feed
Filed
Jul 14, 2023 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2023 · Mar 31, 2023 68.6M sh
Cash And Equivalents restated FY 2023 · Mar 31, 2022 $18.43M
Stockholders Equity FY 2023 · Mar 31, 2022 $12.28M
Current Liabilities restated FY 2023 · Mar 31, 2022 $50.52M
Total Liabilities restated FY 2023 · Mar 31, 2022 $50.52M
Current Assets restated FY 2023 · Mar 31, 2022 $62.81M
Total Assets restated FY 2023 · Mar 31, 2022 $62.81M
Stock Issued FY 2023 · Aug 9, 2021 6.34M sh
Shares Diluted FY 2023 · Mar 31, 2021 48.84M sh
Operating Cash Flow FY 2023 · Mar 31, 2021 $10.06M
Eps Diluted FY 2023 · Mar 31, 2021 −$0.71
Eps Basic FY 2023 · Mar 31, 2021 −$0.71
Net Income FY 2023 · Mar 31, 2021 −$34.83M
Operating Income restated FY 2023 · Mar 31, 2021 −$4.24M